InsightfulValue
← Home

Takeda Pharmaceutical
Takeda Pharmaceutical

Pharma / Pharmaceuticals, Healthcare


πŸ”§ Tools

βœ… Due Diligence
🧩 Revenue Segmentation by Product

Switch to Location
Fiscal year Segment Value
2024 Elaprase 91.56B
2024 Adderall XR 41.76B
2024 Other Rare Hematology 47.3B
2024 Oncology 462.36B
2024 Immunoglobulin 644.59B
2024 PDT Immunology 818.57B
2024 Velcade 5.54B
2024 Takhzyro 178.68B
2024 Leuplin/Enantone 107.35B
Takeda Pharmaceutical

πŸ’° Explore more revenue segmentation data for Takeda Pharmaceutical!

Sign up for free or log in

πŸ™Œ Join now to get "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" at no cost

© 2024 - 2025 InsightfulValue.com. All rights reserved. Newsletter
Legal